Month: April 2022

MORRISVILLE, N.C., April 20, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced that Sandeep Sahay, MD, from Houston Methodist Hospital will present clinical data from studies of YUTREPIA™ (treprostinil) inhalation powder, previously referred to as LIQ861, at the 42nd Annual Meeting of International Society for Heart and Lung Transplant (ISHLT) in Boston, Massachusetts. Presentation details of the oral, pre-recorded presentation are as follows:Title: Risk Assessment in Pulmonary Arterial Hypertension (PAH): Insights from the INSPIRE Study with LIQ861   Session: SESS 19 (Oral) – Risky Business in Pulmonary Hypertension   Abstract Number: 55   Date/Time: Wednesday, April 27; 3:30 p.m. – 3:40 p.m. ET   Location:  Ballroom AA copy of the presentation...

NEBULIZED FORMULATION BEING DEVELOPED TO IMPROVE LUNG FUNCTION IN BOTH ACTIVE-DISEASE COVID-19 PATIENTS AND “LONG HAUL” PATIENTS WITH POST-INFECTION PULMONARY DISEASE SEATTLE, April 20, 2022 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with a current focus on breast cancer and COVID-19, today announces it has completed enrolling participants in Part B of its Phase 1/2a clinical study of AT-H201 in Australia, consisting of multiple ascending dose cohorts in healthy participants. AT-H201 is being developed as an inhalation therapy for moderately to severely ill hospitalized COVID-19 patients and for “long-haul” patients with post-infection pulmonary disease. “Part...

‘The Genesis Collections’ are designed to demonstrate the power of tokenized ownership with a multi-year roadmap comprised of 10 premium NFT projects on the Ethereum blockchain Kennett Square, PA, April 20, 2022 (GLOBE NEWSWIRE) — Good Gaming, Inc. (OTCQB: GMER) (the “Company”), an innovative game publishing company focused on a broad range of interactive entertainment experiences since 2008, today announced the next evolution of its MicroBuddies™ project with the launch of a new digital collectible PFP project, The Genesis Collections. “We are thrilled to announce the launch of The Genesis Collections and our entrance into the digital collectible space, the most popular category in the booming NFT market,” said David Dorwart, Chairman and CEO of Good Gaming. “We believe this next evolution...

Reno, NV , April 20, 2022 (GLOBE NEWSWIRE) — Brookmount Explorations, Inc. (OTC Pink: BMXI) (“Brookmount”), is pleased to provide this update to shareholders on its financial results for the quarter ending Feb 28, 2022. The Company reported revenue from gold sales of $4.01 million for the period, up by 33% over the corresponding quarter in 2021. Net income for the quarter was marginally in excess of $1.9 million, an increase of 46% over the corresponding period in 2021. Earnings per share for the quarter were $0.11/share. Operations at the Company’s Talawaan site have continued to perform strongly and provide the backbone for recent strong operating results as excavation and processing of a high yield ore seam has continued. Additionally, management is pleased to note that Covid-19 restrictions are beginning to lift...

Location of the Kiniero Project Location of the Kiniero ProjectDistrict scale opportunity District scale opportunityQUÉBEC CITY, April 20, 2022 (GLOBE NEWSWIRE) — Robex Resources Inc. (“Robex ”, “the Group” or “the Company”) (TSXV: RBX) and Sycamore Mining Ltd (“Sycamore”), a privately owned company of Cyprus, are pleased to announce that they have entered into a share purchase agreement (the “SPA”) whereby Robex and Sycamore will combine their respective businesses to build a multi-asset and multi jurisdiction gold mining company (the “Transaction”). Transaction summaryPurchase price payable through the issuance of a maximum of 403,600,000 common shares (less customary closing adjustments such as potential liabilities) in the share capital of Robex (“Robex Shares”).Resulting shareholding: Upon completion, Robex shareholders...

Proceeds To Fund Research and Development of BWV-101, BWV-102 and BWV-103 CINCINNATI, April 20, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced the closing of its previously announced private placement of 1,180,812 shares of common stock (or common stock equivalents in lieu thereof), that was priced at-the-market under Nasdaq rules. The Company also issued to investors unregistered preferred investment options (the “investment options”) to purchase up to an aggregate of 1,180,812 shares of common stock. The purchase price for one share of common stock (or common stock equivalent) and one investment option was $6.775. The investment options have an exercise...

Generates US$2 million incremental annual contract value in a single quarter in North America for government sector alone Incremental revenue generated from government entities across 31 U.S states and 2 provinces in Canada demonstrating attractiveness, breadth and reach of Nearmap offering Nearmap technology and content now used by government customers in 42 out of the 50 U.S. states where it offers location dataSALT LAKE CITY, April 20, 2022 (GLOBE NEWSWIRE) — Leading location intelligence and aerial imagery company Nearmap Ltd (NEA:ASX) is providing a further update on its North American business, having exceeded more than US$2 million in incremental annual contract value (ACV) from its government portfolio in North America in a single quarter (Q3 FY22). This announcement continues the strong momentum for the Australian-headquartered...